Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Status:
Terminated
Trial end date:
2012-01-06
Target enrollment:
Participant gender:
Summary
RATIONALE: Methadone hydrochloride may reduce chronic neuropathic pain in patients with
cancer.
PURPOSE: This phase I trial is studying the side effects and best dose of methadone
hydrochloride as first-line therapy in treating patients with chronic neuropathic cancer
pain.